查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
糖尿病用筆型注射器市場 - 成長，未來展望，競爭分析，2022年～2030年
市場調查報告書
商品編碼
1167501

糖尿病用筆型注射器市場 - 成長，未來展望，競爭分析，2022年～2030年

Diabetes Injection Pens Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球糖尿病用筆型注射器市場相關調查，提供市場概要，以及各適應症，各產品，不同形態，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 糖尿病用筆型注射器市場:競爭分析

  • 主要的糖尿病用筆型注射器市場供應商的市場定位
  • 糖尿病用筆型注射器市場供應商僱用的策略
  • 主要的產業策略
  • 階層分析2021年對2030年

第4章 糖尿病用筆型注射器市場:常量分析和市場動態

  • 簡介
  • 全球糖尿病用筆型注射器的市場價值，2020年～2030年，(100萬美元)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析

第5章 糖尿病用筆型注射器市場:各適應症，2020年～2030年，(100萬美元)

  • 市場概要
  • 成長和收益分析:2021年對2030年
  • 市場區隔
    • I型糖尿病
    • II型糖尿病

第6章 糖尿病用筆型注射器市場:各產品，2020年～2030年，(100萬美元)

  • 市場概要
  • 成長和收益分析:2021年對2030年
  • 市場區隔
    • 胰島素筆針
    • 胰島素筆針用針

第7章 糖尿病用筆型注射器市場:不同形態，2020年～2030年，(100萬美元)

  • 市場概要
  • 成長和收益分析:2021年對2030年
  • 市場區隔
    • 拋棄式
    • 可重複使用

第8章 北美的糖尿病用筆型注射器市場，2020年～2030年，(100萬美元)

第9章 英國及EU的糖尿病用筆型注射器市場，2020年～2030年，(100萬美元)

第10章 亞太地區的糖尿病用筆型注射器市場，2020年～2030年，(100萬美元)

第11章 南美的糖尿病用筆型注射器市場，2020年～2030年，(100萬美元)

第12章 中東·非洲的糖尿病用筆型注射器市場，2020年～2030年，(100萬美元)

第13章 企業簡介

  • AstraZeneca plc
  • Becton, Dickinson and Company
  • Biocon Ltd.
  • Eli Lilly and Company
  • Jiangsu Delfu Co.
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Wockhardt Ltd.
  • 其他
Product Code: 137482-08-22

The purpose of this research study titled 'Diabetes Injection Pens Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030' is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market. This report presents and analyzes the major trends prevalent in the global diabetes injection pens market and the market size and forecast.

This report categorizes the global diabetes injection pens market in terms of Diabetes type, product type, form and geographical distribution. Based on diabetes type, the global diabetes injection pens market is categorized into type I and type II diabetes. Insulin pens and insulin pen needles are the major product types considered in this study. Furthermore, disposable and reusable forms of diabetes injection pens are also studies in this report. Market size and forecast for each mentioned segment for the period 2020-2030 is presented in the report along with respective CAGRs for the forecast duration 2022-2030.

The market size and forecast of each considered geographical market is presented for the period 2020-2030 along with CAGRs for the forecast period 2022-2030 in this study and are further cross-sectional presented in terms of diabetes type, product type, form, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.

Injection pens are observed to be administered in both type I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to large patient population belonging to this condition. In addition, since type II diabetes majorly occurs in adult individuals, rational insulin administration through injection pens is highly prevalent. However, increasing patient base of children suffering with type II diabetes presents lucrative penetration opportunity to the diabetes injection pens manufacturers. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used across patients worldwide. However, it is observed that reusable pens are more preferred in developed markets. It is anticipated that the same trend will continue through the forecast period, with higher preference for disposable injection forms being more preferred in developing economies.

Geographically, the global diabetes injection pens market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global diabetes injection pens market. In North America and globally, the United States captures the largest revenue share. The dominance of United States is attributed to large diabetic population, better reimbursement system and healthcare awareness about treatment and management of diabetes. The Europe market, however, is observed to be saturated and will undergo average growth rate. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for diabetes injection pens. Growing awareness and increased ability of patients to pay for advanced medicine are the key driving factors for Asia Pacific diabetes injection pens market.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetes Injection Pens market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Diabetes Injection Pens market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS

Research Period 2020-2030

Base Year 2021

Forecast Period 2022-2030

Historical Year 2020

Unit USD Million

Segmentation

Indication

Type I Diabetes

Type II Diabetes

Product

Insulin Pens

Insulin Pen Needles

Form

Disposable

Reusable

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Diabetes Injection Pens market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Diabetes Injection Pens market?

Which is the largest regional market for Diabetes Injection Pens market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Diabetes Injection Pens market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetes Injection Pens market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Diabetes Injection Pens Market
  • 2.2. Global Diabetes Injection Pens Market, By Indication, 2021 (US$ Million)
  • 2.3. Global Diabetes Injection Pens Market, By Product, 2021 (US$ Million)
  • 2.4. Global Diabetes Injection Pens Market, By Form, 2021 (US$ Million)
  • 2.5. Global Diabetes Injection Pens Market, By Geography, 2021 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2021

3. Diabetes Injection Pens Market: Competitive Analysis

  • 3.1. Market Positioning of Key Diabetes Injection Pens Market Vendors
  • 3.2. Strategies Adopted by Diabetes Injection Pens Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Diabetes Injection Pens Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Diabetes Injection Pens Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Type I Diabetes
    • 5.3.2. Type II Diabetes

6. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Insulin Pens
    • 6.3.2. Insulin Pen Needles

7. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Disposable
    • 7.3.2. Reusable

8. North America Diabetes Injection Pens Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
  • 8.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
  • 8.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
  • 8.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 8.5.1.1.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.1.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 8.5.1.2.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.2.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 8.5.1.3.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.3.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

9. UK and European Union Diabetes Injection Pens Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
  • 9.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
  • 9.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
  • 9.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.1.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.1.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.2.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.2.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.3.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.3.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.4.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.4.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.5.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.5.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 9.5.1.6.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.6.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

10. Asia Pacific Diabetes Injection Pens Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
  • 10.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
  • 10.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
  • 10.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.1.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.1.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.2.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.2.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.3.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.3.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.4.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.4.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.5.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.5.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 10.5.1.6.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.6.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

11. Latin America Diabetes Injection Pens Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
  • 11.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
  • 11.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
  • 11.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 11.5.1.1.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.1.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 11.5.1.2.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.2.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 11.5.1.3.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.3.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

12. Middle East and Africa Diabetes Injection Pens Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
  • 12.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
  • 12.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
  • 12.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 12.5.1.1.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.1.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 12.5.1.2.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.2.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
        • 12.5.1.3.1. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.3.1. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)

13. Company Profile

  • 13.1. AstraZeneca plc
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Becton, Dickinson and Company
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Biocon Ltd.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Eli Lilly and Company
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Jiangsu Delfu Co.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Novo Nordisk A/S
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Owen Mumford Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Wockhardt Ltd.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Other Notable Players
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 2 Global Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 3 Global Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 4 North America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 5 North America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 6 North America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 7 U.S. Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 8 U.S. Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 9 U.S. Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 10 Canada Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 11 Canada Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 12 Canada Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 19 UK Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 20 UK Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 21 UK Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 22 Germany Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 23 Germany Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 24 Germany Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 25 Spain Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 26 Spain Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 27 Spain Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 28 Italy Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 29 Italy Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Italy Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 31 France Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 32 France Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 33 France Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 37 Asia Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 38 Asia Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 39 Asia Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 40 China Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 41 China Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 42 China Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 43 Japan Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 44 Japan Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 45 Japan Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 46 India Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 47 India Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 48 India Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 49 Australia Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 50 Australia Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 51 Australia Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 52 South Korea Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 53 South Korea Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 54 South Korea Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 55 Latin America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 56 Latin America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 57 Latin America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 58 Brazil Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 59 Brazil Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 60 Brazil Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 61 Mexico Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 62 Mexico Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 63 Mexico Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 70 GCC Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 71 GCC Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 72 GCC Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 73 Africa Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 74 Africa Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 75 Africa Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Diabetes Injection Pens Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Diabetes Injection Pens Market: Quality Assurance
  • FIG. 5 Global Diabetes Injection Pens Market, By Indication, 2021
  • FIG. 6 Global Diabetes Injection Pens Market, By Product, 2021
  • FIG. 7 Global Diabetes Injection Pens Market, By Form, 2021
  • FIG. 8 Global Diabetes Injection Pens Market, By Geography, 2021
  • FIG. 9 Market Geographical Opportunity Matrix - Global Diabetes Injection Pens Market, 2021
  • FIG. 10 Market Positioning of Key Diabetes Injection Pens Market Players, 2021
  • FIG. 11 Global Diabetes Injection Pens Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 12 Global Diabetes Injection Pens Market, By Indication, 2021 Vs 2030, %
  • FIG. 13 Global Diabetes Injection Pens Market, By Product, 2021 Vs 2030, %
  • FIG. 14 Global Diabetes Injection Pens Market, By Form, 2021 Vs 2030, %
  • FIG. 15 U.S. Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 16 Canada Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 17 Rest of North America Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 18 UK Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 19 Germany Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 20 Spain Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 21 Italy Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 22 France Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 23 Rest of Europe Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 24 China Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 25 Japan Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 26 India Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 27 Australia Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 28 South Korea Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 29 Rest of Asia Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 30 Brazil Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 31 Mexico Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 32 Rest of Latin America Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 33 GCC Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 34 Africa Diabetes Injection Pens Market (US$ Million), 2020 - 2030
  • FIG. 35 Rest of Middle East and Africa Diabetes Injection Pens Market (US$ Million), 2020 - 2030